Mija, L. A. and Elkrief, A. (2025) “Clinical Considerations for the Management of Advanced PD-L1 ≥50% Non-small Cell Lung Cancer In 2025: Should All Patients Be Treated the Same?”, Canadian Oncology Today, 2(1), pp. 13–17. doi: 10.58931/cot.2025.2131.